gabapentin and haloperidol

gabapentin has been researched along with haloperidol in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.35)18.2507
2000's10 (43.48)29.6817
2010's8 (34.78)24.3611
2020's4 (17.39)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Peng, Y; Welsh, WJ; Zhang, Q1
Gordon, SM; Regan, WM1
Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG1
Klein, S; Nicolas, LB; Prinssen, EP1
Demily, C; Franck, N1
Attupurath, R; Aziz, R; Muralee, S; Tampi, RR; Wollman, D1
Espinosa-Juárez, JV; Jaramillo-Morales, OA; López-Muñoz, FJ1
Dougan, B; Kashiwagi, D; Mauck, K; Regan, DW; Sundsted, K1
Ceretta, APC; de Freitas, CM; de Moraes Reis, E; Dotto, MM; Fachinetto, R; Machado-de-Ávila, RA; Reinheimer, JB; Schaffer, LF; Scussel, R1
Rouse, S; Wodziak, M1
Déciga-Campos, M; Espinosa-Juárez, JV; Jaramillo-Morales, OA; López-Muñoz, FJ; Villafán-Gutiérrez, R1
Akgül, E; Engin, EF; Ertan Akan, G; Polat, B1
Li, H; Li, P; Li, S; Wang, R1

Reviews

5 review(s) available for gabapentin and haloperidol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
    Southern medical journal, 2001, Volume: 94, Issue:3

    Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid

2001
Update in perioperative medicine: practice changing evidence published in 2016.
    Hospital practice (1995), 2017, Volume: 45, Issue:4

    Topics: Amines; Analgesics; Anticoagulants; Antipsychotic Agents; Arthritis, Rheumatoid; Blood Transfusion; Cyclohexanecarboxylic Acids; Cyclooxygenase 2 Inhibitors; Delirium; Disease Progression; Evidence-Based Practice; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Hemorrhage; Humans; Pain, Postoperative; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Risk Assessment; Surgical Wound Infection; Thromboembolism; Tumor Necrosis Factor-alpha

2017
Intractable Hiccups.
    Current neurology and neuroscience reports, 2018, 06-22, Volume: 18, Issue:8

    Topics: Anticonvulsants; Dopamine Antagonists; Gabapentin; Haloperidol; Hiccup; Humans

2018
Different interventions for preventing postoperative catheter-related bladder discomfort: a systematic review and meta-analysis.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:6

    Topics: Chlorpheniramine; Dexmedetomidine; Gabapentin; Haloperidol; Humans; Ketamine; Lidocaine; Meperidine; Nefopam; Pain, Postoperative; Pregabalin; Tolterodine Tartrate; Tramadol; Urinary Bladder; Urinary Catheters

2022

Other Studies

18 other study(ies) available for gabapentin and haloperidol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.
    Journal of medicinal chemistry, 2021, 01-14, Volume: 64, Issue:1

    Topics: Animals; Binding Sites; Blood-Brain Barrier; Drug Design; Guinea Pigs; Half-Life; Humans; Microsomes, Liver; Molecular Dynamics Simulation; Neuralgia; Pain Management; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship; Rats; Receptors, sigma; Sigma-1 Receptor; Triazoles

2021
Gabapentin for behavioral agitation in Alzheimer's disease.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1

    Topics: Acetates; Aged; Alzheimer Disease; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Psychomotor Agitation; Treatment Outcome

1997
Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats.
    Psychopharmacology, 2007, Volume: 194, Issue:2

    Topics: Amines; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Bridged Bicyclo Compounds; Buspirone; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Diazepam; Dose-Response Relationship, Drug; Escape Reaction; Fear; Freezing Reaction, Cataleptic; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Imidazoles; Male; Morphine; Motor Activity; Nociceptin Receptor; Pregabalin; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, Opioid; Spiro Compounds; Thiazoles; Ultrasonics

2007
Gabapentin for ultra resistant schizophrenia with aggressive behavior.
    Schizophrenia research, 2008, Volume: 100, Issue:1-3

    Topics: Adult; Aggression; Amines; Anticonvulsants; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Male; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Violence

2008
Chorea associated with gabapentin use in an elderly man.
    The American journal of geriatric pharmacotherapy, 2009, Volume: 7, Issue:4

    Topics: Aged; Amines; Analgesics; Anti-Dyskinesia Agents; Anxiety; Chorea; Cognition Disorders; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Neuropsychological Tests

2009
Haloperidol Decreases Hyperalgesia and Allodynia Induced by Chronic Constriction Injury.
    Basic & clinical pharmacology & toxicology, 2017, Volume: 121, Issue:6

    Topics: Amines; Analgesics; Animals; Antipsychotic Agents; Chronic Disease; Constriction, Pathologic; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Hyperalgesia; Injections, Spinal; Male; Neuralgia; Pain Measurement; Piperazines; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Sulpiride

2017
Gabapentin reduces haloperidol-induced vacuous chewing movements in mice.
    Pharmacology, biochemistry, and behavior, 2018, Volume: 166

    Topics: Animals; Anti-Anxiety Agents; Anti-Dyskinesia Agents; Dopamine Antagonists; GABA Modulators; Gabapentin; Haloperidol; Male; Mastication; Mice

2018
Synergistic interaction between haloperidol and gabapentin in a model of neuropathic nociception in rat.
    European journal of pharmacology, 2021, Jan-15, Volume: 891

    Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Gabapentin; Haloperidol; Hyperalgesia; Male; Nociception; Nociceptive Pain; Rats, Wistar; Receptors, sigma; Sciatica; Sigma-1 Receptor; Signal Transduction

2021
Cerebral proliferative angiopathy accompanied by cerebral cavernous malformation: A case report.
    Clinical neurology and neurosurgery, 2021, Volume: 210

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Cerebral Small Vessel Diseases; Gabapentin; Haloperidol; Hemangioma, Cavernous, Central Nervous System; Humans; Male

2021